Latest Period
Q4 2025
Security Snapshot
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) Institutional Ownership
CUSIP: 810648105
13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$5.67
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- SCPH
- Shares outstanding
- 53,364,241
- Price per share
- $5.67
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 0
- Total reported value
- $0
- Share change
- -40,924,004
- Value change
- -$232,019,505
- Number of holders
- 0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 810648105.
- 0 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 108 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $232,212,551 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 0 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 810648105:
Significant Owners of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC | 4.6% | $11,829,640 | 2,474,820 | Glazer Capital, LLC | 02 Sep 2025 | |||
| KING LUTHER CAPITAL MANAGEMENT CORP | 4% | -43% | $11,982,841 | -$8,674,586 | 2,128,391 | -42% | Luther King Capital Management Corporation | 30 Sep 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH). This represents 0% of the company’s total 53,364,241 outstanding shares.
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$232,019,505 | $5.67 | 0 |
| 2025 Q3 | 40,958,051 | $232,212,551 | +$31,413,737 | $5.67 | 108 |
| 2025 Q2 | 38,194,973 | $145,545,847 | +$3,415,856 | $3.81 | 95 |
| 2025 Q1 | 37,545,308 | $98,742,458 | -$7,793,831 | $2.63 | 87 |
| 2024 Q4 | 39,775,602 | $140,807,820 | +$5,279,129 | $3.54 | 84 |
| 2024 Q3 | 37,253,566 | $169,822,547 | +$42,711,046 | $4.56 | 93 |
| 2024 Q2 | 27,815,340 | $121,012,490 | +$4,504,277 | $4.35 | 77 |
| 2024 Q1 | 26,737,974 | $134,225,727 | -$7,908,753 | $5.02 | 76 |
| 2023 Q4 | 27,975,859 | $175,412,395 | -$21,478,357 | $6.27 | 79 |
| 2023 Q3 | 29,932,073 | $213,117,843 | +$9,111,651 | $7.12 | 73 |
| 2023 Q2 | 28,536,920 | $290,787,599 | +$40,687,005 | $10.19 | 81 |
| 2023 Q1 | 24,606,169 | $223,185,472 | +$38,842,993 | $9.07 | 63 |
| 2022 Q4 | 21,410,510 | $153,514,412 | +$53,537,608 | $7.17 | 59 |
| 2022 Q3 | 14,022,022 | $91,281,927 | -$10,765,163 | $6.52 | 38 |
| 2022 Q2 | 15,695,145 | $75,930,511 | -$3,255,361 | $4.82 | 37 |
| 2022 Q1 | 15,882,655 | $90,121,602 | -$464,823 | $5.68 | 34 |
| 2021 Q4 | 15,935,241 | $79,992,923 | -$1,598,866 | $5.02 | 29 |
| 2021 Q3 | 16,228,718 | $107,917,705 | +$1,557,655 | $6.65 | 29 |
| 2021 Q2 | 16,027,286 | $97,921,582 | -$7,160,512 | $6.11 | 35 |
| 2021 Q1 | 17,151,321 | $114,054,500 | +$1,499,774 | $6.65 | 45 |
| 2020 Q4 | 16,944,254 | $89,636,480 | -$6,272,494 | $5.29 | 46 |
| 2020 Q3 | 17,093,245 | $127,345,487 | -$3,281,426 | $7.45 | 48 |
| 2020 Q2 | 17,536,133 | $129,064,483 | +$37,153,425 | $7.36 | 51 |
| 2020 Q1 | 12,488,415 | $92,413,167 | +$10,168,930 | $7.40 | 32 |
| 2019 Q4 | 11,121,954 | $62,947,464 | +$1,581,064 | $5.65 | 27 |
| 2019 Q3 | 7,577,638 | $44,502,550 | +$1,469,868 | $5.89 | 24 |
| 2019 Q2 | 7,370,534 | $23,510,457 | -$286,179 | $3.19 | 28 |
| 2019 Q1 | 7,483,932 | $22,451,653 | -$1,275,253 | $3.00 | 32 |
| 2018 Q4 | 7,846,766 | $29,504,290 | -$830,389 | $3.76 | 32 |
| 2018 Q3 | 8,056,307 | $47,291,256 | -$192,971 | $5.87 | 31 |
| 2018 Q2 | 8,090,838 | $45,789,211 | -$6,149,684 | $5.66 | 37 |
| 2018 Q1 | 8,320,407 | $103,170,760 | +$6,465,196 | $12.40 | 37 |
| 2017 Q4 | 7,806,672 | $94,381,000 | +$94,381,000 | $12.09 | 24 |